|
« back
Ms. Spiliotes is currently President and co-founder of ValeoVox and has more than 25 years experience in new venture development in both national and international markets. She has served as an executive advisor to Fortune 500 companies in the healthcare, financial services, publishing, information technology, consumer products and retail industries. Prior to ValeoVox, Ms. Spiliotes served in a strategic advisory role to emerging technology companies in the biopharmaceuticals arena at Leerink Swann & Co. working with early and mid-stage companies to secure financing through venture capital and strategic partnerships for business development and revenue growth. Before joining Leerink Swann, Ms. Spiliotes was founder and CEO of Predictive Sciences, Inc., an Internet start-up, employing new media and interactive technologies to advance collaborative care in the management of chronic diseases. Ms. Spiliotes was also a VP and Director of RR Donnelley Financial, where she had responsibility for running the Healthcare Communications Business. Through her management leadership and experience with other firms such as Computer Sciences Corporation, Arthur D. Little, Inc., and The Alexander Group, Ms. Spiliotes has worked with clients to maximize growth and profitability of existing and new businesses. Ms. Spiliotes is a recipient of a Robert Woods Johnson Foundation grant to develop interactive health management tools for the Hispanic community. She sits on the advisory boards of the Simmons School of Management Entrepreneurship Program and FiatLux Imaging, Inc. and is a board member and director of Speak 2B Free. She received a B.A. in Neuroscience from Smith College and a M.Sc. in Management from the Sloan School of Management at MIT.
Power your growth using our products and services. Contact us today for more information.
|
